CYMERE Trademark
Serial Number: 79266160
CYMERE is a trademark filed by
EXOPHARM LIMITED
on July 19, 2019. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently no longer active.
Trademark Classes
Owner Contact Info
Trademark Details
Filing Date
July 19, 2019
Registration Date
Not Registered
Goods & Services
Cellular function activating agents for medical purposes; therapeutic pharmaceutical for the treatment of wounds, skin conditions, orthopaedic conditions including sarcopenia, osteoarthritis and tendinopathy, degenerative eye disease including age related macular degeneration, age related conditions, neurodegenerative disease, depression, bleeding, trauma, stroke, heart disease
Filing History
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Jul 18, 2021 DENA
DEATH OF INTERNATIONAL REGISTRATION
Jul 17, 2021 DETH
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 22, 2021 OPNX
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 8, 2021 RCSC
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 3, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 3, 2021 OPNR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 18, 2020 ADCH
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 26, 2020 RCSC
ASSIGNED TO LIE
Jun 25, 2020 ALIE
ASSIGNED TO EXAMINER
May 26, 2020 DOCK
REFUSAL PROCESSED BY IB
Dec 20, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 26, 2019 RFCS
REFUSAL PROCESSED BY MPU
Nov 26, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 5, 2019 RFCR
SUSPENSION LETTER WRITTEN
Nov 4, 2019 CNSL
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Oct 30, 2019 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 10, 2019 RFCR
SUSPENSION LETTER WRITTEN
Oct 9, 2019 CNSL
ASSIGNED TO EXAMINER
Oct 4, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 13, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 9, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 29, 2019 REPR
